Publicaciones en colaboración con investigadores/as de University College Dublin (2)

2020

  1. The rate of bone loss slows after 1–2 years of initial antiretroviral therapy: final results of the Strategic Timing of Antiretroviral Therapy (START) bone mineral density substudy

    HIV Medicine, Vol. 21, Núm. 1, pp. 64-70

2018

  1. Tenofovir alafenamide plus emtricitabine versus abacavir plus lamivudine for treatment of virologically suppressed HIV-1-infected adults: a randomised, double-blind, active-controlled, non-inferiority phase 3 trial

    The Lancet HIV, Vol. 5, Núm. 4, pp. e162-e171